Answers are grounded in this paper and cite their sources.
Pediatric thyroid cancer is rising with an estimated incidence of 1.4 cases per 100,000 children per year and favorable survival outcomes; however, certain vulnerable populations present with more advanced disease, have poorer disease-specific survival, and face disparities in treatment. The problem is complex and multifactorial, though common factors are race/ethnicity, language proficiency, socioeconomic status including income and insurance status, and access to care. The aim of this review is to illustrate the various disparities that impact pediatric thyroid cancer presentation, treatment differences, and outcomes, while also providing multipronged solutions that can help curb patient outcome differences.
No takes yet. Share an insight, caveat, or question.
Solis et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: